Technology and DCT have enormous potential. But discernment is key; we must learn from what worked and didn't, integrating technologies that enhance patient-centricity without overloading sites.

Joined by Nael Abdelsamad and his extensive experience, we’ll navigate the shift towards decentralized trials to leveraging AI and machine learning, uncovering the keys to sustained innovation and patient-centricity. Nael has dedicated his career to clinical operations and trial management, working with prestigious medical centers and renowned organizations like CVS Health. Discover how technology integration, big data utilization, and workforce development are shaping the future landscape of clinical trials.

Join us as we discuss:

• Challenges and opportunities in the clinical trial industry, particularly in the wake of COVID-19
• The decentralized clinical trials (DCT) model
• The thoughtful incorporation of AI and machine learning
• Connectivity between all platforms and integration capabilities
• The importance of reducing tech overload and enhancing workforce development.

What steps can industry leaders take to foster standardization and cooperation among different technological platforms?

In this episode, Rick Malone, previous president of the McCreadie Group and current Business Development Director at Inovalon, shares his strategic vision navigating the ever-evolving landscape of clinical research, where he emphasizes the importance of collaboration between pharma companies, CROs, and research sites to achieve standardized workflows and a more efficient research process.
Join us as we discuss:

• The challenges facing the industry today and the exciting opportunities for the future.
• The next horizon of the industry with the use of electronic systems.
• The key role of vendors finding  interoperability and connectivity.
• How to improve trials for patients.
• The potential of data integration and automation to streamline clinical trials and improve the site experience.

Have you ever wondered how advanced technology could revolutionize clinical trials? This is disruptive innovation, using technology to seamlessly solve the clinical industry's biggest challenges.

In this enlightening episode, we're joined by Dr Gordon Harris, co-founder and Chief Science Officer at Yunu, where they've found the biggest challenges and problems to solve, from being a solution for one site to being able to handle all sites within a trial. Dr. Harris will guide us on how to manage different imaging criteria, bridge communication gaps and streamline trial management with technology, platforms and tools, taking into account the importance of building a robust and connected ecosystem across the industry.

Join us as we discuss:

• Using technology to streamline trial processes and deliver a better service.
• How to ensure global network, site connectivity and process consistency.
• How to truly expand access to care and clinical trials with innovative approaches.
• The relationship between imaging assessment and imaging data for pharma companies.
• The importance of having naive optimism and never settling for the status quo. 

With an industry that is based on data and numbers, it's important to stay ahead of the game. It's what you do in the present that will redeem the past and thereby change the future.

For this episode, we’re joined by Mazhar Jaffry, a physician doctor with extensive experience in the marketing sales business development, and is the founder and CEO of Revival Research Institute, LLC. Dr. Jaffry talks about his journey with a rich history of experience and his aim to take the organization to the top of the industry in the coming years, with ambitious goals to revolutionize clinical trials. He shares all the big innovations and challenges that are coming, because to embrace the future of healthcare we must accept its ever-evolving changes.

Join us as we discuss:

• Dr. Jaffry’s passion for learning and educating people
• Revival Research Institute's growth, focus, and goals
• Data management, diversity, patient retention, and other challenges facing clinical trials
• The need for a very strong network and the importance of partnership
• Big innovations in patient care and processes 
• Impact of COVID-19 in the evolution of the industry

The only way to drive innovation and improve the efficiency of the sector is to create alliances and be collaborative; to be able to do more together than separately with patient-centered objectives.

In this episode, we discuss the challenges and innovations that are transforming the landscape of drug development and clinical trials, and how we can grow in a market with so many players. Carlos Orantes, CEO of Alconza Clinical Research, shares his insights from over 30 years of experience in the industry, and dives into the importance of collaboration and teamwork to address all the industry challenges, emphasizing on the main objective: An approach centered on the patient.

Join us as we discuss:

• How innovation in technology is playing an important role in streamlining processes and the positive impact on patient care, experience, participation and diversity
• Insights and advice for the future of clinical trials, focusing on the impact of the patients and sites while removing barriers and finding opportunities around the world
• The role of FDA guidelines in driving innovation, particularly in diversity and decentralization
• The significance of continuous learning and mentorship in staying innovative

Innovation that makes a difference is driven by the people that it impacts the most and is focused on value propositions.

In today's episode, we delve into the pivotal shift towards digital over the past seven years. Matt Smith, VP of Research Site Development at Slope, emphasizes the necessity of streamlining research processes and making the lives of those involved in research easier. Matt explains how efficiency, standardization, and interoperability emerge as focal points for improvement, with an eye on AI to revolutionize processes and provide a free platform for research organizations.

Join as we discuss:

• Integrating technology into the workflow of research sites to streamline processes and improve efficiency for sponsors and vendors
• Innovation driven by the needs of research sites to reduce risk and save time in clinical trials
• How collaborative platforms like Slope can simplify technology usage across trials and empower research sites, sponsors, & vendors

Our latest guest is Sandy Smith, Senior VP of Clinical Solutions and Strategic Partnerships at WCG, a company that connects sponsors, CROs, sites, and participants to deliver efficient, safe and impactful clinical research.

In this conversation, Sandy shares insights into her background as an advanced practice nurse and how she landed 3 years ago at WCG where she leads Clinical Solutions and Strategic Partnership to solve some of the biggest challenges in research. In this talk, Sandy will touch on her role connecting diverse stakeholders (sites, sponsors, CROs), while advocating for the patient’s voice. She will emphasize the convergence of clinical care and research in oncology, while getting us excited about the future of innovation.

Join as we discuss:

• Challenges posed by technology complexity, resourcing issues, and the overall increased complexity of modern trials
• The importance of patient-specific data to reduce trial timelines without compromising quality
• The potential of AI and machine learning in identifying optimal sites, patient identification, and recruitment

Accreditation and standardization are the keys to driving positive change in the clinical research industry, leaving a lasting legacy and making strides toward global collaboration.

Today we’re joined by Jacqueline Johnson North, CEO and Co-Founder of GCSA. The Global Clinical Site Assessment Standard enables clinical research sites, CROs, and sponsors to work synergistically, while fostering a truly patient-centric system. We discuss the development of a certification standard for clinical research sites, the 7-module approach of their assessment, and the impact on the industry.

Join as we discuss:

• The role of GCSA in overcoming barriers and building a patient-centric system
• The value of certification standards in driving positive change in the industry
• The need for collaboration and innovation to improve the efficiency and effectiveness of clinical research

The success of any piece of software or solution = the quality of the solution x the buy-in and adoption of that solution.

In today’s episode, our guest Dave Hine Senior Director of Sales Engineering at Greenphire, shares his unique journey from aerospace engineering to the clinical trial industry. The conversation highlights the importance of patient-centricity, explores Greenphire's innovative solutions, and delves into the challenges of patient enrollment. Dave shares insights on industry trends, has a clear vision for the future of clinical trials, and offers valuable advice for those entering the field.

Join as we discuss:

• The crucial intersection of technology and patient-centricity in the clinical trial industry
• Appropriate expectation setting and addressing feasibility issues to increase patient enrollment
• Proactive approaches to address challenges and enhance the overall patient experience

A unified system that enhances patient care, improves outcomes, and advances research to ensure the right patients receive the right therapies…

That’s the goal.

Our latest guest, Melisa Tucker, is a healthcare industry expert with a significant background in healthcare innovation and data utilization. She is currently serving as Head of Research Evidence Generation Program at Verily. Melisa discusses her journey in the clinical research landscape, emphasizing the importance of working with great people and staying curious to seize opportunities for personal and professional growth. The episode delves into the evolving receptiveness of the healthcare industry to technology, particularly in the context of unstructured data and AI. Melisa envisions a future where a single, comprehensive source of healthcare data can power better patient care and transform clinical research. The episode provides insights into the ongoing innovations and potential impact in healthcare technology and research.

Join as we discuss:

• The role of technology and innovation in clinical research
• Receptiveness of the healthcare industry to technology
• Potential of unstructured data and AI in healthcare
• The vision for a unified source of healthcare data
• Importance of working with inspiring individuals
• Opportunities for career growth in the healthcare industry